Corporate Actions & Capital Structure › Sub-category
Buyback
8 articles
Indian companies are increasingly utilizing share buybacks to return capital to shareholders, reflecting robust financial performance and a positive outlook. Go Fashion executed a ₹6.5 billion buyback alongside a 37% drop in profit, while eClerx completed a ₹3 billion buyback alongside a bonus share issue and 22% revenue growth. These actions, combined with broader trends of companies like Rolex Rings and SIS engaging in buybacks, suggest a willingness to deploy excess capital and potentially support equity valuations; however, investors should monitor underlying growth and profitability trends to assess the sustainability of these capital return programs.
Advanced Enzyme Q1 FY27 Revenue Up 2% YoY
Advanced Enzyme reported Q1 FY27 revenue of ₹1,898 million, a 2% YoY increase but 7% sequential decline impacted by a ₹100 million sales reversal.
EBITDA declined 10% YoY to ₹510 million with margins
Surya Roshni Q1 FY27 PAT Up 77% YoY
Surya Roshni reported Q1 FY27 consolidated revenue of ₹2,046 crore, up 28% YoY, with PAT surging 77% to ₹60 crore.
Steel division revenue grew 32% to ₹1,590 crore with EBITDA per ton at ₹4,006, while
Puretrop Fruits 34th Annual Report FY26 Submission
Puretrop Fruits submits 34th Annual Report for FY25-26 to BSE, announcing AGM on September 15, 2026 via video conference.
Company reports revenue growth of 9.12% to ₹121.88 crore and profit turnaround
Go Fashion FY26 Revenue ₹838Cr, PAT Drops 37%
Go Fashion reported FY26 revenue of ₹838.01 crore with PAT declining 36.7% to ₹59.18 crore while maintaining gross margin at 63.2%.
The company executed a share buyback of 14.13 lakh shares at ₹460 pe
eClerx FY2026 Reports 22% Revenue Growth, Bonus Issue
eClerx Services Limited reported 22.3% YoY operating revenue growth to ₹41,170.26 million and 30.5% PAT growth to ₹7,062.11 million for FY2026.
The company completed a ₹3,000 million share buyback and
Gandhi Special Tubes Approves ₹78.12 Crore Share Buyback
Gandhi Special Tubes shareholders approved a special resolution for buyback of up to 8.68 lakh equity shares at ₹900 per share via tender offer.
The ₹78.12 crore buyback represents 7.14% of paid-up ca
Windlas Biotech Q1 FY27 Revenue Hits Record ₹248 Crore
Windlas Biotech reported its highest-ever quarterly revenue of ₹248 crore, an 18% YoY growth, marking 14 consecutive quarters of record revenue.
The company completed a ₹47 crore buyback and declared
Zydus Lifesciences Insiders' Buyback Share Acceptance
Zydus Lifesciences discloses insider share transactions under SEBI regulations related to its recent buyback offer.
Promoter Zydus Family Trust accepted 63.5 lakh shares, reducing its holding from 74.